内科综合减重方案治疗肥胖型2型糖尿病患者临床效果.docVIP

内科综合减重方案治疗肥胖型2型糖尿病患者临床效果 　　[摘要] 目的 探讨内科药物治疗联合减重方案治疗肥胖型2型糖尿病效果。方法 选取2016年7月―2017年7月收治的肥胖型2型糖尿病患者80例，分为对照组和观察组，两组均采用药物治疗，观察组联合减重方案，对比两种治疗方案的效果，对比两组患者治疗前后各项生理指标的变化情况。结果 观察组治疗总有效率明显高于对照组，两组治疗后指标均较治疗前有所改善，但是观察组的改善幅度更大，差异有统计学意义（P0.05）。结论 内科治疗联合减重方案效果更为理想，治疗总有效率明显提高，患者的各项指标均改善趋于稳定。 　　[关键词] 内科治疗；减重方案；肥胖型糖尿病 　　[中图分类号] R587.1；R589.2 [文献标识码] A [文章编号] 1672-4062（2017）12（a）-0025-02 　　[Abstract] Objective This paper tries to investigate the effect of medical treatment combined with weight loss on obesity type 2 diabetes mellitus. Methods 80 obese patients with type 2 diabetes mellitus from July 2016 to July 2017 were divided into control group and observation group. The two groups were treated with drugs， the observation group combined with weight loss program， compared the effects of the two treatment regimens， compared the two groups of patients before and after treatment and the changes in physiological indicators. Results The total effective rate in the observation group was significantly higher than that in the control group. Both indexes in the two groups were improved after treatment， but the improvement in the observation group was larger. The difference was statistically significant （P0.05）. Conclusion The combination of medical therapy and weight loss regimen is more effective and the total effective rate of treatment is significantly improved. All the indexes of the patients were improved and stabilized. 　　[Key words] Internal medicine treatment； Weight loss program； Obesity diabetes 　　糖尿病是临床上常见慢性代谢性疾病，发病与众多因素有关，肥胖是该病发生的独立危险因素，而且过度肥胖可能会加重患者病情的恶化，加重患者的病情，甚至可能引起严重的胰岛素抵抗[1]，不利于疾病的治疗和恢复，由此可见针对肥胖型2型糖尿病在实施药物治疗的基础上，联合减肥治疗也至关重要。该文选取该院于2016年7月―2017年7月期间收治的肥胖2型糖尿病患者80例，着重就药物联合减重方案治疗的效果进行分析，现报道如下。 　　1 资料与方法 　　1.1 一般资料 　　选取该院收治的肥胖2型糖尿病患者80例，平均年龄（69.38±6.59）岁，平均体重质量指数为（27.62±1.26）kg/m2；随机分为对照组和观察组，就各种基本资料进行对比，差异无统计学意义（P0.05）。 　　1.2 纳入与排除标准 　　①两组患者血糖指标和体重指数等均符合肥胖型糖尿病标准[2]；②两组患者均为初次接受相关治疗；③排除合并肝肾功能不全、合并严重并发症患者；④两组患者均无精神认知障碍，无无故中途退出者。 　　1.3 治疗方法 　　给予两组患者口服二甲双胍联合注射甘精胰岛素治疗，